Points to consider on the requirements for clinical documentation for metered dose inhalers (MDI) Addendum on neuropathic pain to the Note for Guidance on clinical investigation of medicinal products for nociceptive Pain treatment Note for Guidance on Clinical Investigation of Medical Products in the Treatment of Generalised Anxiety Disorder Note for Guidance on Clinical Investigation of Medical Products in the Treatment of Panic Disorder.
Document title Points to consider on the clinical development of fibrinolytic medicinal products in the treatment of patients with ST segment elevation acute myocardial infarction (STEMI)